Biodesix, Inc. (BDSX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Biodesix, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Biodesix, Inc. (BDSX) has returned 113.24% so far this year and 15.96% over the past 12 months.

Based on dividend-adjusted daily data since Oct 28, 2020, BDSX's average daily return is -0.01%, while the average monthly return is -1.80%.

Historically, 36% of months were positive and 64% were negative. The best month was Nov 2022 with a return of +98.0%, while the worst month was May 2025 at -43.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 14 months.

On a daily basis, BDSX closed higher 44% of trading days. The best single day was Jan 12, 2026 with a return of +48.0%, while the worst single day was May 14, 2025 at -38.7%.

Biodesix, Inc. has an annualized alpha of -14.56%, beta of 0.91, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 29, 2020.

• This stock participated in 163.46% of S&P 500 Index downside but only -49.48% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BDSX ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Biodesix, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biodesix, Inc. was 99.30%, occurring on May 14, 2025. The portfolio has not yet recovered.

The current Biodesix, Inc. drawdown is 97.68%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Biodesix, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Biodesix, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.